Madrona leads $60M investment into AI-powered drug discovery company Terray Therapeutics

Pasadena, Calif.-based Terray Therapeutics, which combines nanotechnology with artificial intelligence, has raised $60 million in a Series A funding round led by Seattle’s Madrona Venture Group. Terray’s chips are fit with millions of molecules that can be used for drug-target screening, with the resulting data fed into machine learning models. Madrona has historically backed tech companies but is increasingly investing…
« Previous post: | Next post: »